AG MED
0563.933.452 · rovalta.com · 25/09/2026
ACTIVE
AG MED
Financial year 2025 · Closed on 30/06/2025
Net result192 k €-0,2 %over 1 year
Gross margin308,7 k €+11,0 %over 1 year
Equity861,1 k €+28,7 %over 1 year
Overview
Identity
Source · BCE/KBOAG MED is a Private limited company incorporated in 2014. Its registered office is in Waterloo.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0563.933.452
- Incorporation
- 13/10/2014
- Legal form
- Private limited company
- Registered office
- Clos de Differdange 14
1410 Waterloo · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 308,7 k € | +11.0% | 278,1 k € | +2.4% | 271,5 k € | +12.7% | 240,9 k € | +3.0% | 233,8 k € |
| EBITDA | 308,5 k € | +11.0% | 277,9 k € | +2.4% | 271,3 k € | +12.9% | 240,4 k € | +3.7% | 231,7 k € |
| Operating result | 294,9 k € | +11.1% | 265,4 k € | -0.1% | 265,7 k € | +14.3% | 232,4 k € | +4.5% | 222,4 k € |
| Net result | 192 k € | -0.2% | 192,4 k € | +13.1% | 170,1 k € | +19.2% | 142,6 k € | -4.9% | 150 k € |
| Balance sheet | |||||||||
| Equity | 861,1 k € | +28.7% | 669,1 k € | 0.0% | 669,1 k € | +34.1% | 499,1 k € | +7.3% | 465,2 k € |
| Total assets | 1,4 M € | +7.2% | 1,3 M € | +4.2% | 1,2 M € | +16.9% | 1,1 M € | -3.9% | 1,1 M € |
| Cash | 1,2 M € | +75.2% | 691,9 k € | -34.4% | 1,1 M € | +5.9% | 995,6 k € | -3.6% | 1 M € |
| Debts | 494,5 k € | -18.3% | 605,4 k € | +9.1% | 555,1 k € | +1.2% | 548,4 k € | -15.2% | 646,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20252 active · 3 ended
Active mandates
JEAN-MICHEL GHILAIN
ActiveMARIE-CATHERINE ABELOOS
ActiveEnded mandates
JEAN-MICHEL GHILAIN
EndedMARIE CATHERINE ABELOOS
EndedMARIE-CATHERINE ABELOOS
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/12/2025 | 12/12/2024 | 12/12/2023 | 16/12/2022 | 13/12/2021 | 07/12/2020 |
| General meeting | 21/12/2025 | 11/12/2024 | 11/12/2023 | 13/12/2022 | 06/12/2021 | 02/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 21/12/2025 | 22/12/2025 | French | |
| Micro model | 30/06/2024 | 11/12/2024 | 12/12/2024 | French | |
| Micro model | 30/06/2023 | 11/12/2023 | 12/12/2023 | French | |
| Micro model | 30/06/2022 | 13/12/2022 | 16/12/2022 | French | |
| Micro model | 30/06/2021 | 06/12/2021 | 13/12/2021 | French | |
| Micro model | 30/06/2020 | 02/12/2020 | 07/12/2020 | French | |
| Micro model | 30/06/2019 | 09/12/2019 | 10/12/2019 | French | |
| Micro model | 30/06/2018 | 19/12/2018 | 20/12/2018 | French | |
| Micro model | 30/06/2017 | 11/12/2017 | 20/12/2017 | French | |
| Abridged model | 30/06/2016 | 02/12/2016 | 21/12/2016 | French | |
| Abridged model | 30/06/2015 | 01/12/2015 | 16/12/2015 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20252 active · 3 ended
Active mandates
JEAN-MICHEL GHILAIN
ActiveMARIE-CATHERINE ABELOOS
ActiveEnded mandates
JEAN-MICHEL GHILAIN
EndedMARIE CATHERINE ABELOOS
EndedMARIE-CATHERINE ABELOOS
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025192 k €↓
- 2024Annual accounts 2024192,4 k €↑
- 2023Annual accounts 2023170,1 k €↑
- 2022Annual accounts 2022142,6 k €↓
- 2021Annual accounts 2021150 k €↓
- 2020Annual accounts 2020183,8 k €↓
- 2019Annual accounts 2019225,7 k €↑
- 2018Annual accounts 2018184,2 k €↓
- 2017Annual accounts 2017195,5 k €↑
- 2016Annual accounts 2016170,7 k €↑
- 2015Annual accounts 2015120,4 k €
- 13/10/2014IncorporationPrivate limited company